Biological features of premalignant disease in the human breast (Q35671149)

9 August 2017

1 reference

title

Biological features of premalignant disease in the human breast (English)

1 reference

9 August 2017

Allred DC

1

1 reference

PubMed ID

14973381

9 August 2017

Mohsin SK

series ordinal

2

1 reference

9 August 2017

1 October 2000

1 reference

Journal of Mammary Gland Biology and Neoplasia

9 August 2017

1 reference

9 August 2017

5

1 reference

9 August 2017

4

1 reference

9 August 2017

351-364

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1009573710675

9 August 2017

0 references

cites work

Immunophenotype of intraductal carcinoma

1 reference

12 December 2020

Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.

1 reference

12 December 2020

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas

1 reference

12 December 2020

[Pathological characterization of atypical ductal hyperplasia of the breast]

1 reference

12 December 2020

Expression of p53 protein in infiltrating and in-situ breast carcinomas

1 reference

12 December 2020

Proliferative and secretory activity in human breast during natural and artificial menstrual cycles

1 reference

12 December 2020

Nuclear receptor coactivators and corepressors

1 reference

12 December 2020

Benign breast disease and breast cancer: a case-control study in a cohort in Italy

1 reference

12 December 2020

Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones

1 reference

12 December 2020

Cell proliferation in the human mammary epithelium. Differential contribution by epithelial and myoepithelial cells

1 reference

12 December 2020

c-erbB-2 expression in benign and malignant breast disease

1 reference

12 December 2020

bcl-2 expression in the spectrum of preinvasive breast lesions

1 reference

12 December 2020

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer

1 reference

12 December 2020

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

1 reference

12 December 2020

Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Flow cytometric and histological analysis of ductal carcinoma in situ of the breast

1 reference

12 December 2020

The neu-oncogene: more than a prognostic indicator?

1 reference

12 December 2020

Intraductal carcinoma of the breast: Follow-up after biopsy only

1 reference

12 December 2020

Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal-deoxynucleotidyl-transferase-mediated dUTP-FITC nick end labelling

1 reference

12 December 2020

Immunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive

1 reference

12 December 2020

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

1 reference

12 December 2020

The neu-protein and breast cancer

1 reference

12 December 2020

p53 accumulation in benign breast biopsy specimens

1 reference

12 December 2020

p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data

1 reference

12 December 2020

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci

1 reference

12 December 2020

Risk factors for breast cancer in women with proliferative breast disease

1 reference

12 December 2020

Influence of age and gland topography on cell kinetics of normal human breast tissue.

1 reference

12 December 2020

neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast.

1 reference

12 December 2020

Abnormal expression of wild type p53 protein in normal cells of a cancer family patient

1 reference

12 December 2020

Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study

1 reference

12 December 2020

Relationship between c-erbB-2 immunoreactivity and thymidine labelling index in breast carcinomain situ

1 reference

12 December 2020

Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast

1 reference

12 December 2020

Estrogen receptor values in patients with benign breast disease

1 reference

12 December 2020

The classification of ductal carcinoma in situ and its association with biological markers

1 reference

12 December 2020

The expression of the neu oncogene product in breast lesions and in normal fetal and adult human tissues.

1 reference

12 December 2020

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease

1 reference

12 December 2020

Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences

1 reference

12 December 2020

Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia

1 reference

12 December 2020

Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions

1 reference

12 December 2020

An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions

1 reference

12 December 2020

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

1 reference

12 December 2020

Loss of heterozygosity in normal tissue adjacent to breast carcinomas.

1 reference

12 December 2020

A correlative morphologic study of human breast and endometrium in the menstrual cycle

1 reference

12 December 2020

Estrogen and progesterone receptors in the normal female breast

1 reference

12 December 2020

p53, the cellular gatekeeper for growth and division

1 reference

12 December 2020

c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma

1 reference

12 December 2020

Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification

1 reference

12 December 2020

Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer

1 reference

12 December 2020

The p185erbB2 protein is localized on cell organelles involved in cell motility.

1 reference

12 December 2020

Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ

1 reference

12 December 2020

Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast

1 reference

12 December 2020

A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions

1 reference

12 December 2020

Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors

1 reference

12 December 2020

Allelic loss and the progression of breast cancer

1 reference

12 December 2020

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

12 December 2020

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

12 December 2020

Molecular genetic studies of early breast cancer evolution

1 reference

12 December 2020

Immunohistochemical study of neu protein overexpression in clinging in situ duct carcinoma of the breast.

1 reference

12 December 2020

Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma--a detailed morphological analysis

1 reference

12 December 2020

Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

1 reference

12 December 2020

Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction

1 reference

12 December 2020

Correlation between ploidy status, Erb-B2 and p53 immunohistochemical expression in primary breast carcinoma

1 reference

12 December 2020

p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast

1 reference

12 December 2020

HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer

1 reference

12 December 2020

Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.

1 reference

12 December 2020

Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Implications of the p53 tumor-suppressor gene in clinical oncology.

1 reference

12 December 2020

Genetic basis for p53 overexpression in human breast cancer

1 reference

12 December 2020

Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

1 reference

12 December 2020

The p53 tumor suppressor gene in breast cancer

1 reference

12 December 2020

Genetic divergence in the clonal evolution of breast cancer

1 reference

12 December 2020

Cell proliferation in fibrocystic disease and postmenopause breast ducts measured by thymidine labeling

1 reference

12 December 2020

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1 reference

12 December 2020

Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.

1 reference

12 December 2020

Cell cycle analysis of normal, atrophic, and hyperplastic breast epithelium using two-color multiparametric flow cytometry

1 reference

12 December 2020

Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer

1 reference

12 December 2020

Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ

1 reference

12 December 2020

Potential value of hormone receptor assay in carcinoma in situ of breast

1 reference

12 December 2020

C-ERBB-2 oncogens protein inIn situ and invasive lobular breast neoplasia

1 reference

12 December 2020

Cell kinetics of histologic variants of in situ breast carcinoma

1 reference

12 December 2020

A prospective study of benign breast disease and the risk of breast cancer

1 reference

12 December 2020

The prevalence of carcinoma in situ in normal and cancer-associated breasts

1 reference

12 December 2020

Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands

1 reference

12 December 2020

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

1 reference

12 December 2020

Anatomic indicators (histologic and cytologic) of increased breast cancer risk

1 reference

12 December 2020

Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia

1 reference

12 December 2020

Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.

1 reference

12 December 2020

TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast

1 reference

12 December 2020

On the origin and progression of ductal carcinoma in the human breast

1 reference

12 December 2020

Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1 reference

12 December 2020

Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters

1 reference

12 December 2020

Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry

1 reference

12 December 2020

Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression

1 reference

12 December 2020

Receptors for estrogen and progesterone in breast carcinoma in situ

1 reference

12 December 2020

Loss of heterozygosity in lobular carcinoma in situ of the breast

1 reference

12 December 2020

Thymidine labeling index and Ki-67 growth fraction in lesions of the breast

1 reference

12 December 2020

Comparative Studies of Cancerous Versus Noncancerous Breasts

1 reference

12 December 2020

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia

1 reference

12 December 2020

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

1 reference

12 December 2020

Loss of heterozygosity in ductal carcinoma in situ of the breast.

1 reference

12 December 2020

Feulgen DNA content and mitotic activity in proliferative breast disease. A comparison with ductal carcinoma in situ.

1 reference

12 December 2020

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

1 reference

12 December 2020

Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

1 reference

12 December 2020

High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers

1 reference

12 December 2020

The effect of age and menstrual cycle upon proliferative activity of the normal human breast

1 reference

12 December 2020

Distribution of estrogen receptor in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast

1 reference

12 December 2020

Extensive apoptosis in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ

1 reference

12 December 2020

Epithelial stem cells and their possible role in the development of the normal and diseased human breast

1 reference

12 December 2020

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

12 December 2020

Modulation of biomarkers in minimal breast carcinoma: a model for human breast carcinoma progression

1 reference

12 December 2020

Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1009573710675

1 reference

PubMed ID

14973381

Dimensions Publication ID

9 August 2017

0 references

1 reference

PubMed ID

14973381